Works matching IS 14397595 AND DT 2021 AND VI 31 AND IP 5


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.

    Published in:
    Modern Rheumatology, 2021, v. 31, n. 5, p. 972, doi. 10.1080/14397595.2020.1847802
    By:
    • Yushiro Endo;
    • Shoichi Fukui;
    • Kunihiko Umekita;
    • Takahisa Suzuki;
    • Junya Miyamoto;
    • Shimpei Morimoto;
    • Toshimasa Shimizu;
    • Tomohiro Koga;
    • Shin-ya Kawashiri;
    • Naoki Iwamoto;
    • Kunihiro Ichinose;
    • Mami Tamai;
    • Tomoki Origuchi;
    • Akitomo Okada;
    • Keita Fujikawa;
    • Akinari Mizokami;
    • Naoki Matsuoka;
    • Toshiyuki Aramaki;
    • Yukitaka Ueki;
    • Katsumi Eguchi
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21